To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
146 Current news from österreich
rss23-04-2013
The protective effect of inducing controlled hypothermia following sudden cardiac arrest will now be investigated in detail. The goal of the scientific work is to judge whether this type of cryotherapy can be improved when using parallel simultaneous invasive resuscitation procedures. ...
07-03-2013
Analytical chemists have measured the levels of selected organic compounds found in human breath, with the aim of one day applying the technique to the routine diagnosis of disease. The analysis of biomarkers in exhaled air and in blood can reveal the presence of cancer, the rejection of ...
05-03-2013
Grazed skin grows back quickly, dead heart tissue does not. This is why a cardiac arrest often leads to severe long term problems. At the Vienna University of Technology, chemical substances have been developed, which turn the body’s own progenitor cells into functioning, beating heart cells. ...
06-02-2013
Using Laser Technology, Aleksandr Ovsianikov from the Vienna University of Technology wants to create microstructures with embedded living cells. This project will be funded by an ERC Starting Grant. The behavior of cells strongly depends on their environment. If they are to be researched an ...
01-02-2013
A signalling molecule known as Axl has been discovered on immune cells of the epidermis. This recently published finding provides new insight into the development of important skin immune cells known as Langerhans cells. These cells fight off invading microorganisms and play a crucial role in ...
16-01-2013
Horizon Discovery Ltd announced it has signed a research service collaboration agreement with Boehringer Ingelheim. Horizon will support Boehringer Ingelheim’s oncology programs by using its Discovery Toolbox for research projects and profiling of compounds at the hit-to-lead, lead ...
14-01-2013
Hookipa Biotech AG announced the formation of its Scientific Advisory Board (SAB). The SAB is chaired by Emeritus Prof. Dr. Paul-Henri Lambert (PhD), former Chief of Vaccine Research and Development for the WHO Global Program for Vaccines and Immunizations. The members include scientists ...
11-01-2013
Hookipa Biotech AG announced the appointment of two new members to its Management team: Thomas P. Monath as Chief Medical Officer and Farshad Guirakhoo as Chief Scientific Officer. Dr. Thomas P. Monath, serving as consulting Chief Medical Officer will play a key role in setting up Hookipa´s ...
07-01-2013
Evotec AG announced that Evotec and Apeiron Biologics have entered into a research collaboration with the objective of developing immunomodulatory lead compounds for the treatment of cancer. Apeiron Biologics will contribute in vitro and in vivo pharmacology expertise to this collaboration ...
19-12-2012
Anton Paar is proud to announce the opening of three new subsidiaries on January 1, 2013. New offices will begin work in Poland, South Africa and Brazil. Brazil: The headquarters ofAnton Paar Brasil Ltda. will be located in Sao Paulo. Sales and service will be coordinated here for all product ...



